Immune Therapy in Autism: Historical Experience and Future Directions with Immunomodulatory Therapy
Authors:
- Michael G. ChezMCMichael G. Chez
- Natalie Guido-EstradaNGNatalie Guido-Estrada
- 1 July 2010
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 7 (3) , 293-301
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum DisordersNeuropsychopharmacology, 2009
- Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic DrugsNew England Journal of Medicine, 2009
- Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administrationJournal of Neuroinflammation, 2008
- Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6The Journal of Neuroscience, 2007
- Poster session 1: Neurodevelopment and movement disorders (P39–P70)Annals of Neurology, 2007
- Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signalingMolecular Psychiatry, 2007
- Elevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic ChildrenPediatric Neurology, 2007
- A genetic variant that disrupts MET transcription is associated with autismProceedings of the National Academy of Sciences, 2006
- Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndromeThe Journal of Pediatrics, 2000
- Reversible behavioural autistic-like regression: A manifestation of a special (new?) epileptic syndrome in a 28-month-old child. A 2-year longitudinal studyNeurocase, 1995